Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Edwards Lifesciences Corp EW

Healthcare Medical Devices
Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.


NYSE:EW - Post by User

Edwards Lifesciences Corp
<< Previous
 Bullboard Posts
User Avatar Image
(227)
•••
Post by whytestockson Oct 26, 2024 7:45pm
100 Views
Post# 36283691

EW FRAUD NEWS: Edwards Lifesciences Sued for Securities Frau

EW FRAUD NEWS: Edwards Lifesciences Sued for Securities Frau
News; $EW EW FRAUD NEWS: Edwards Lifesciences Sued for Securities Fraud after Stock Plummets 31%; Investors with Losses Urged to Contact BFA Law by December 13 Court DeadlineNEW YORK, NY / ACCESSWIRE / October 26, 2024 / Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securiti...EW - EW FRAUD NEWS: Edwards Lifesciences Sued for Securities Fraud after Stock Plummets 31%; Investors with Losses Urged to Contact BFA Law by December 13 Court Deadline

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities